For the past 10 years, Benefits Canada’s Chronic Disease at Work conference has examined the current trends in chronic disease in Canada and what they mean for plan sponsors. Hosted in a virtual format on Feb. 12, the 2025 conference explored several chronic diseases, as well as their impacts on the workplace and the role of employers […]
Chronic disease rates are rising and cases are becoming more complex, with a higher share of plan members experiencing multiple co-morbidities. This growing trend necessitates an approach to chronic disease management that promotes self-management and healthy lifestyle choices, as well as helps plan members better navigate the health-care landscape, said Jeffery Chan, assistant vice-president of […]
Obesity is one of the most misunderstood diseases, with stigma and judgement contributing to the misconceptions, said Lisa Schaffer, executive director at Obesity Canada, during a session supported by Eli Lilly Canada at Benefits Canada’s 2025 Chronic Disease at Work conference. Obesity is associated with more than 200 chronic illnesses and nearly one in three […]
When a 49-year-old woman attended Dr. Phil McFarlane’s multi-care kidney clinic with polycystic kidney disease, she had multiple health issues, including chronic flank pain and fatigue, and had been to the emergency room multiple times. She was dealing with a “high anxiety burden” from her health issues, the financial burden from the necessary medications and […]
Women over the age of 40 represent a quarter of the Canadian working population, with those between the ages of 45 and 55 the fastest growing cohort of working women. Those ages coincide with the time period when women are most likely to begin perimenopause and menopause, making it incumbent on employers to create menopause-inclusive […]
Benefits Canada’s Face to Face Drug Plan Management Forum has been running for nearly 20 years and is the industry’s most popular drug benefits conference. On Dec. 2 at the Omni King Edward Hotel in Toronto, attendees experienced a full day of educational sessions presented by industry experts, with insights into fresh drug plan designs […]
Attention deficit hyperactivity disorder is a neurodevelopmental disorder, affecting up to nine per cent of children and five per cent of adults, said Marie-Hélène Dugal, manager of pharmacy benefit strategy at Medavie Blue Cross, during Benefits Canada’s 2024 Face to Face Drug Plan Management Forum. Diagnosis rates have increased among women and become more common […]
Women face unique health challenges throughout their lives — across most age groups, women experience higher rates of chronic diseases compared to men, said Neda Nasseri, pharmacist and product director of drug benefits at Desjardins Insurance, during a session supported by Pfizer Canada at Benefits Canada’s 2024 Face to Face Drug Plan Management Forum. Historically, […]
Canada’s workforce increasingly reflects the unique health challenges faced by its female population. Between 2018 and 2023, women represented a little more than half of the total claimants and spend in Express Scripts Canada’s drug claims data, according to Farah Belayadi, the organization’s senior manager of clinical services and health technology database, during Benefits Canada’s […]
Breast cancer is the most common cancer in Canada, predominantly affecting women, with more than 29,000 diagnoses in 2023. It’s complexity is underscored by more than 50 unique types, making each diagnosis distinct and challenging to treat, according to Kimberly Carson, chief executive officer of Breast Cancer Canada, during a session supported by AstraZeneca Canada […]